A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity
about
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in ChildrenReview article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.Thioguanine in inflammatory bowel disease: Long-term efficacy and safetyColonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism.Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.Optimizing pharmacologic management of inflammatory bowel disease.The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.Neutralizing IL-23 is superior to blocking IL-17 in suppressing intestinal inflammation in a spontaneous murine colitis model.Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study.Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification.Critical assessment of thioguanine treatment for inflammatory bowel diseases: Is it time to rehabilitate this treatment?Colonic thioguanine pro-drug: Investigation of microbiome and novel host metabolism.Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.The long persistence of pyrrolizidine alkaloid-derived DNA adducts in vivo: kinetic study following single and multiple exposures in male ICR mice.Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease.Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol-thiopurine cotherapy
P2860
Q26798470-105E82ED-1566-4C9F-9920-E26E0DF752ADQ33410771-2E0362ED-25B4-4725-A33F-00F0F523ADC3Q33654733-AD48F918-C4CB-4E47-B415-3BC85B1196BEQ33731976-E5373149-8377-4A8C-B600-B4B666B8CE86Q37600072-19E66426-D614-4EDB-B8CF-116026535581Q38563075-089C17D8-953F-4C24-9EEF-752F4A822528Q38687407-997DFEFA-9364-45CF-9FE6-256EA205361DQ39534066-F03ADB15-7F4D-435C-98D8-4F7997E8660EQ41389903-8F73E78F-34FC-4D60-8D7B-35724CCAA456Q44577440-AB0AED72-0B24-46DB-BF8D-155A4CDBCB3EQ47756139-29E0390F-2732-4953-8230-EDB70C08482BQ48188262-3F9093AC-F3B5-4839-B3C7-063117285818Q49618167-8E4EE0BD-89A1-402A-9C68-F501E204D439Q50217361-33A20AED-EEAF-4962-90A5-4AFE2C5A3772Q53112364-BBF33DCE-977E-4082-92CE-9959C5E02802Q54357723-B1B778DC-9154-46F6-A2BE-19B2F7F4C153Q58763029-820B0862-AC87-4813-A3DA-CBD8D9B89F2E
P2860
A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A novel mouse model of veno-oc ...... anine-induced hepatic toxicity
@ast
A novel mouse model of veno-oc ...... anine-induced hepatic toxicity
@en
A novel mouse model of veno-oc ...... anine-induced hepatic toxicity
@nl
type
label
A novel mouse model of veno-oc ...... anine-induced hepatic toxicity
@ast
A novel mouse model of veno-oc ...... anine-induced hepatic toxicity
@en
A novel mouse model of veno-oc ...... anine-induced hepatic toxicity
@nl
prefLabel
A novel mouse model of veno-oc ...... anine-induced hepatic toxicity
@ast
A novel mouse model of veno-oc ...... anine-induced hepatic toxicity
@en
A novel mouse model of veno-oc ...... anine-induced hepatic toxicity
@nl
P2093
P50
P1433
P1476
A novel mouse model of veno-oc ...... anine-induced hepatic toxicity
@en
P2093
Brett C McWhinney
Chin Wen Png
H A Jinnah
Ingrid G Winkler
John A Duley
Timothy H J Florin
P304
P356
10.1136/GUTJNL-2012-302274
P407
P50
P577
2012-07-07T00:00:00Z